PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
暂无分享,去创建一个
K. Rahbar | B. Hadaschik | K. Herrmann | M. Weckesser | M. Schäfers | J. Kleesiek | W. Fendler | R. Seifert | Manuel Weber | K. Kessel | M. Boegemann | K. Schlack | Maximilian Spanke